Dendritic cell subtypes work in concert to activate ... Immunicum is also advancing the development of DCP-001 as a cell-based relapse vaccine. Because DCP-001 cells are derived from a cancer ...

dendritic cells, and lymphocytes). Vector production (clinical-grade plasmid DNA and retroviral vectors). Research and development work relating to vector production and transduction of patient cells.

Potential autoimmune diseases therapies that target dendritic cells aim to either inhibit immunogenic dendritic cell functions or support their tolerogenic potential (Figure 2). Most strategies ...